about
Ablative approaches to the minimally invasive treatment of breast cancer.Cognitive problems among breast cancer survivors: loneliness enhances riskRe-emphasizing the concept of adequacy of intraoperative assessment of the axillary sentinel lymph nodes for identifying nodal positivity during breast cancer surgery.Social support and socioeconomic status interact to predict Epstein-Barr virus latency in women awaiting diagnosis or newly diagnosed with breast cancer.Angiosarcoma and breast cancer recurrence eight years following mammosite therapy.Beta-blockers may reduce intrusive thoughts in newly diagnosed cancer patients.Plasma MicroRNA Levels Following Resection of Metastatic Melanoma.Pain, depression, and fatigue: loneliness as a longitudinal risk factor.Insulin-like growth factor binding protein-3 is upregulated in LPS-treated THP-1 cells.Treatment and Prognosis of Rare Breast Cancers.Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma.Breast Cancer Genetics for the Surgeon: An Update on Causes and Testing Options.Sentinel Lymph Node Biopsy for Recurrent Melanoma: A Multicenter Study.The Impact of Smoking on Sentinel Node Metastasis of Primary Cutaneous Melanoma.ATM mutations for surgeons.Healthcare Costs Reduced After Incorporating the Results of the American College of Surgeons Oncology Group Z0011 Trial into Clinical Practice.Living post treatment: definitions of those with history and no history of cancer.Perception of cancer recurrence risk: more information is better.Pharmacokinetics and clinical evaluation of 125I-radiolabeled humanized CC49 monoclonal antibody (HuCC49deltaC(H)2) in recurrent and metastatic colorectal cancer patients.Surveillance strategies in the follow-up of melanoma patients: too much or not enough?Clinically relevant lessons from Family HealthLink: a cancer and coronary heart disease familial risk assessment tool.Minimal Clinical Impact of Intraoperative Examination of Sentinel Lymph Nodes in Patients With Ductal Carcinoma In Situ: An Opportunity for Improved Resource Utilization.Timing of Breast Cancer Surgery-How Much Does It Matter?Isolated supraclavicular lymph node recurrence after breast-conserving surgery and negative axillary sentinel node biopsy.Influence of the TNF-alpha and TNF-beta polymorphisms upon infectious risk and outcome in surgical intensive care patients.Pilot Study Using a Humanized CC49 Monoclonal Antibody (HuCC49°CH2) to Localize Recurrent Colorectal CarcinomaDoes the number of sentinel lymph nodes removed affect the false negative rate for head and neck melanoma?Immune Checkpoint Inhibitor Therapy as a Novel and Effective Therapy for Aggressive Cutaneous Squamous-cell CarcinomaHuman toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infectionsModulation of the lipopolysaccharide receptor complex (CD14, TLR4, MD-2) and toll-like receptor 2 in systemic inflammatory response syndrome-positive patients with and without infection: relationship to toleranceUtilization of genetic counseling services by surgical oncologists: education a mustHead and neck melanoma in the sentinel lymph node eraProspective randomized clinical trial comparing intradermal, intraparenchymal, and subareolar injection routes for sentinel lymph node mapping and biopsy in breast cancerTrends in breast cancer presentation and care according to age in a single institutionContralateral prophylactic mastectomy for unilateral breast cancer: an increasing trend at a single institutionCost-effectiveness of sentinel lymph node biopsy in thin melanomas
P50
Q31159987-6282245A-B8EB-4F26-8218-CA1846358532Q33358246-D846C5E7-E65C-460C-8EAF-161028C89BC5Q35636158-E77A7B82-5C75-4C77-A224-186C16B2407DQ35663693-40E09A3C-9A2B-4C5B-B5D9-75CE8D4FFE70Q35742582-3539BB35-52F9-456F-86D7-CDBC760A3CC1Q36729423-F569CA81-618F-43E3-B78B-842F6A56C082Q37693673-B8A6045B-AA1C-41B6-AC0E-397CBA7CDB56Q37712526-9798346C-2D2D-48B7-B6CD-D4B51CDCD0B2Q38358904-E3263539-E3DB-44F0-A55D-6FD0DA20B390Q38563866-E9FCA0BD-4A6B-4FDB-8C79-EAE30D3B2C30Q38738044-8430AC4B-895F-43F8-AB69-F14A8B65E713Q38770304-E130E746-A9FF-4C71-AA24-2F4F8DB08198Q38784286-E469FB52-0CCD-42F7-B678-0E5F0EB811DDQ38948856-190F58F8-E08D-4981-BCA6-FF75D1BBF697Q39042363-B68BB775-C381-442F-A045-6F227533D7E2Q39143694-1F021819-3F5C-4E19-8607-E51283E9F5A9Q44962462-E411B097-BB17-4870-95F3-656C8968218AQ44972140-DFA953AC-0ECA-4990-B8E2-196041426E72Q46391338-84296BCB-8972-49F1-B36E-E290AA943363Q47343489-4FD3BAB1-D6D5-4FC9-9B8F-D3C571B78CDBQ48256947-1E8FE426-3CDF-4FEA-9D1D-74BE3D47F3DAQ50089010-8B9FF9C8-6447-4025-ABAE-645F8DDA6764Q50936037-9BA05055-6EA7-459C-910A-E112BB233EDDQ53638306-B4AB3CAA-5428-497B-AFE0-606BD4E70A38Q54761437-25FF15EE-CA42-41B4-8F02-AB24E0216102Q57450995-6C256A6A-E01E-4416-8928-0255452E9D1EQ59496918-2DB1B7DE-0574-4F33-A4B0-AE5B588E60B7Q59497147-803D1269-5D2A-4E85-8A59-A678EE0B4F22Q78439420-5AC312E4-1664-4879-A9D1-65DF894C8FFBQ79167557-92EA9853-4A97-4515-B784-CBC6363CBCFEQ79353584-DFAC7C19-DDEE-4B58-A6A5-6684446CA0F0Q79912957-E04F91E6-E2A7-44AE-8764-F659873FD8CEQ80224905-01984517-0B0D-4E61-A8CE-054988A916D0Q80841880-5D0EB9C8-6E9B-4E36-97FD-4C43F4818829Q84024696-A4B966DB-7DE2-4417-B684-72B0D31D338DQ94327687-5076E44A-BCC3-4E07-A426-6A641F807310
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Doreen M Agnese
@ast
Doreen M Agnese
@en
Doreen M Agnese
@es
Doreen M Agnese
@nl
type
label
Doreen M Agnese
@ast
Doreen M Agnese
@en
Doreen M Agnese
@es
Doreen M Agnese
@nl
prefLabel
Doreen M Agnese
@ast
Doreen M Agnese
@en
Doreen M Agnese
@es
Doreen M Agnese
@nl
P106
P1153
6602542407
P31
P496
0000-0002-9910-9422